Printer Friendly
The Free Library
14,709,857 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

SAREUM, the specialist cancer drug [...]; MARKET REPORT.


Byline: by Geoff Foster

SAREUM, the specialist cancer drug discovery minnow minnow, common name for the Cyprinidae, a large family of freshwater fish which includes the carp (Cyprinus carpio), and of which there are some 300 American species. The European minnow is Phoxinus phoxinus. , edged up 0.05p to 0.375p. Buyers nibbled away as chief executive Dr Tim Mitchell Mitchell, city (1990 pop. 13,798), seat of Davison co., SE S.Dak.; inc. 1881. Mitchell is a trade, distribution, and shipping center for a dairy and livestock area.  presented its pipeline at the Bio-Europe conference in Vienna. Shop broker Hybridian has a 31/2p target price and says the company is fully funded well into 2011. Meanwhile, bulls reckon reck·on  
v. reck·oned, reck·on·ing, reck·ons

v.tr.
1. To count or compute: reckon the cost. See Synonyms at calculate.

2.
 a tie-up with a major pharmaceuticals group could be on the cards by early next year.
COPYRIGHT 2009 Solo Syndication Limited
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Business
Publication:The Daily Mail (London, England)
Date:Nov 3, 2009
Words:74
Previous Article:MAIN CHANGES.(Business)
Next Article:RACING RESULTS.(Sport)
Topics:



Related Articles
United Kingdom: Tight US pharma research market prompts Sareum into strategic review.
United Kingdom: Galapagos acquires drug discovery assets from Sareum Holdings.
Patients 'must be free to top up NHS treatment'; Denied NHS care: Mr Eckley.
NHSto let patients buy top-up drugs Governments U-turn over unsustainable policy.
Generics And Innovators - Saying I Do And Doing Battle.
New drugs attempt to "starve" cancer: immensely expensive, and no improvement in survival.
PORTFOLIO.(Business)
PORTFOLIO.(Business)
Chinese whisper fuels Gulfsands; MARKET REPORT.(Business)(Industry overview)
SAREUM, the specialist cancer [...]; MARKET REPORT.(Business)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles